AMCP Summit: Perspectives on Value-Based Arrangements & Assessments
As part of AMCP’s strategic priorities, AMCP will continue to encourage the exchange of ideas among stakeholders and initiate solutions that optimize patients’ health outcomes and address barriers to access to care. To that end, AMCP is convening a summit to bring together thought leaders to discuss value-based arrangements and assessments and share their novel, unique perspectives with managed care professionals.
This summit was held on Nov. 9, 2022. Registration is now closed.
After attending this Summit, participants should be able to:
- Discuss the evolution of value-based models and the potential impact on the health care system.
- Explain the different value framework models and their utilization in managed care practice.
- Summarize existing and novel payment models that are being considered for high-investment medications.
- Describe three best practices with value-based contracting that could be utilized in managed care pharmacy practice.
Agenda and Registration
Please note that if you are a registered attendee, you were sent an invitation email to access the virtual event platform from View Email Address. If you haven’t received your invitation to join, check your spam or junk mail or contact us at View Email Address.
If you have any technical questions about the event platform, please direct them to our platform partner, Jujama, at View Email Address. General questions about the Summit or about AMCP should be directed to View Email Address.
Susan A. Cantrell, MHL, RPh, CAE
Chief Executive Officer
Clifford Goodman, PhD
Senior Vice President
The Lewin Group
Keynote Presentation: The Evolving Role of Value in Health Care
Integration of value is a vital component of health care decision-making yet depending on the perspective the definition of value varies. As stakeholder involvement in defining value for health care is expanding, managed care organizations seek strategies to balance patient perspectives, outcomes, affordability, and access. What does value for health care look like in years to come and how do we get there?
Amitabh Chandra, PhD
Ethel Zimmerman Wiener Professor of Public Policy, Harvard Kennedy School
Henry and Allison McCance Professor of Business Administration, Harvard Business School
Best Practices in Assessing Value and the Future of Value Frameworks
With publicly available value framework tools and assessment resources, how are managed care organizations integrating these insights into formulary and policy decision-making? Hear from a few perspectives on their approach to utilize existing value framework tools for their specific population in assessing value and building contracts.
Vice President, Policy, Research & Membership
Kimberly Lenz, PharmD, MBA, FAMCP
Senior Director of Pharmacy
University of Massachusetts Chan Medical School – Commonwealth Medicine, Office of Clinical Affairs/MassHealth
Brian O’Mahony, FACSLM
Irish Haemophilia Society
Kimberly Westrich, MA
Director, Value and Access Strategy
Evolving Strategies to Cover High Investment Medications
Novel therapies, such as gene and cell therapy, are growing in availability and meeting medical needs for previously uncurable conditions. These important and life-saving options are associated with high initial costs raising predictability, affordability, and accessibility concerns for managed care organizations. This session will discuss various perspectives on alternative payment models, financial tools, and policy initiatives that mitigate risk and improve access to these durable cures.
Jane Barlow, MD, MPH, MBA
Chief Clinical Officer
Ronda Copher, PhD
Bristol-Myers Squibb (BMS)
Mehb Khoja, FSA, MAAA
Gail Ryan, PharmD
Director of Pharmaceutical Transformation
Innovations in Value-Based Partnerships for Patient Care Services
As our pharmacy profession advances, managed care organizations are developing innovative approaches to partner with other health care providers and stakeholders to optimize patient care and health outcomes. Hear from these panelists on how they are initiating partnerships in patient care services, the lessons learned along the way, and where they see the future of these partnerships.
Brenden O’Hara, RPh, BCACP
Team Leader, Provider Engagement Pharmacy Initiatives
Blue Cross NC
Todd D. Sorensen, PharmD
Professor and Senior Executive Associate Dean
University of Minnesota
Troy Trygstad, PharmD, MBA, PhD
Call for Innovation: Where Are We Going from Here?
As we wrap up the day, what have you learned? How will you incorporate value into your practice? Join us for this interactive closing of the Summit!
AMCP Summit Registration Fees:
- AMCP Member: Free
- Non-Member: $125